External Nasal Dilator and Oxygen Therapy in Respiratory Failure



Status:Recruiting
Conditions:Hospital, Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:Any - 17
Updated:6/22/2016
Start Date:July 2015
End Date:May 2017
Contact:Anil Kumar Swayampakula
Email:aswayampakula@llu.edu
Phone:9095584250

Use our guide to learn which trials are right for you!

Use of External Nasal Dilator as an Adjuvant to High-Flow Nasal Cannula Oxygen Therapy in Children With Acute Respiratory Failure: A Prospective Randomized Controlled Trial

Acute respiratory failure secondary to bronchiolitis and asthma is one of the most common
diagnoses in children admitted to pediatric intensive care unit.

Objectives: The primary outcome of the study is to compare the respiratory parameters
between patients on HFNC and HFNC with ENDs.

Methods: This is a prospective randomized controlled trial. All children admitted to Loma
Linda University Children's Hospital due to acute respiratory failure secondary to
bronchiolitis and asthma are eligible for inclusion in the study. Multiple respiratory
parameters will be collected as part of the study. The investigators anticipate that use of
END will have a positive impact on the respiratory status of children with acute respiratory
failure. Appropriate statistical analysis of the data will occur after the data has been
de-identified.

Acute respiratory failure secondary to bronchiolitis and asthma is one of the most common
diagnoses in children admitted to pediatric intensive care unit.

Objectives: The primary outcome of the study is to compare the respiratory parameters
between patients on high flow nasal cannula (HFNC) and HFNC with an external nasal dilator
(END).

Methods: This is a prospective randomized controlled trial. All children admitted to Loma
Linda University Children's Hospital between July 2015 and May 2017 for approximately 22
months due to acute respiratory failure secondary to bronchiolitis and asthma are eligible
for inclusion in the study. Two arms will be studied, one with HFNC and the other with HFNC
and ENDS. Modified Bronchiolitis Severity Score and Pediatric Respiratory Assessment
Measurement scores will be used to assess respiratory parameters as part of the study. The
investigators anticipate that use of END will have a positive impact on the respiratory
status of children with acute respiratory failure. Appropriate statistical analysis of the
data will occur after the data has been de-identified.

Inclusion Criteria:

- children less than 18years

- respiratory failure

Exclusion Criteria:

- immediate intubation

- 18y or older
We found this trial at
1
site
Loma Linda, California 92374
Phone: 909-558-4250
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials